Featured Research

from universities, journals, and other organizations

Cancers of sweat glands, other skin-related structures may be increasing in United States

Date:
June 22, 2010
Source:
JAMA and Archives Journals
Summary:
Cutaneous appendageal carcinomas -- tumors of the skin appendages such as hair, nails, sweat glands and mammary glands -- are rare but rates appear to be increasing in the United States, according to a new study.

Cutaneous appendageal carcinomas -- tumors of the skin appendages such as hair, nails, sweat glands and mammary glands -- are rare but rates appear to be increasing in the United States, according to a report in the June issue of Archives of Dermatology, one of the JAMA/Archives journals.

"Cutaneous appendageal carcinomas are a rare and diverse group of complex neoplasms with diverse differentiation that frequently present a diagnostic challenge," the authors write as background information in the article. Because of their rarity, studies of these cancers have been limited.

Patrick W. Blake, B.S., of the National Cancer Institute, Bethesda, Md., and colleagues examined incidence rates, trends and survival rates of the disease using 16 cancer registries in the Surveillance, Epidemiology and End Results Program from 1978 to 2005. A total of 1,801 patients were identified for incidence analysis, 2,228 for trend analysis and 1,984 for survival analysis.

The age-adjusted incidence rates were 5.1 cases per 1 million people per year, with men more likely to develop one of the cancers than women. Hispanic whites, blacks and Asian/Pacific Islanders all had lower rates of incidence than non-Hispanic whites. The most common type was apocrine-eccrine carcinoma, or cancer of the sweat glands. Incidence rates increased with age, with a 100-fold difference between individuals age 20 to 29 years and those age 80 years and older.

Cutaneous appendageal carcinomas also became more common over time, with a 150-percent increase in incidence between 1978 to 1982 and 2002 to 2005. Rates of sweat gland cancers increased 170 percent and sebaceous carcinomas, cancers of glands in the eyelid, increased 217 percent. Overall, five-year survival rates were 99 percent for localized disease and 43 percent for disease that had spread to another part of the body.

"Cutaneous appendageal carcinoma incidence rates are increasing in the United States, especially for sebaceous carcinoma, perhaps related to improved recognition and classification, but factors such as UV exposure and immunosuppression may also play a role," the authors write. "Further increases in cutaneous appendageal carcinomas over time should prompt new strategies for cancer screening and early intervention of this cancer."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Patrick W. Blake; Porcia T. Bradford; Susan S. Devesa; Jorge R. Toro. Cutaneous Appendageal Carcinoma Incidence and Survival Patterns in the United States: A Population-Based Study. Arch Dermatol, 2010; 146 (6): 625-632 [link]

Cite This Page:

JAMA and Archives Journals. "Cancers of sweat glands, other skin-related structures may be increasing in United States." ScienceDaily. ScienceDaily, 22 June 2010. <www.sciencedaily.com/releases/2010/06/100621173737.htm>.
JAMA and Archives Journals. (2010, June 22). Cancers of sweat glands, other skin-related structures may be increasing in United States. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2010/06/100621173737.htm
JAMA and Archives Journals. "Cancers of sweat glands, other skin-related structures may be increasing in United States." ScienceDaily. www.sciencedaily.com/releases/2010/06/100621173737.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins